Sign Up
|
Sign In
Home
US Market
UK Market
News
My Portfolio
Forex
Forum
Cockpit
EuroTrader
Home
»
World
»
North America
»
United States
»
Pharmaceuticals
»
Mylan Inc
Mylan Inc
MYL
(NASDAQ)
Overview
Discussions
Advanced chart
News
Historical data
Recommendations
To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.
Industry
:
Health Care
Sector
:
Pharmaceuticals & Biotechnology
$
21.21
Updated
01:00:01
Change %
1.9%
Change
0.3990
Volume
6,278,048
High
$
21.38
Low
$
20.73
Open
$ 20.83
Prev close
$ 20.81
# of shares
-
Market cap
-
Intraday
Market closed
Tech analysis
Market is closed, opens at 14:30
Price development
Latest
1 week
1 month
3 mon
6 mon
1 year
21.21
0.0%
-2.9%
-9.5%
18.6%
-11.0%
Insufficient flash player version
News about Mylan Inc
Subscribe To RSS Feed
Local
International
Announcements
17 May
UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix
17 May
FDA Approves Generic Versions Of Blood Thinning Drug Plavix
30 April
2nd UPDATE: Warner Chilcott Confirms Strategic Review; In Talks With Potential Suitors
27 April
UPDATE: US Judge Upholds Validity Of Merck's Vytorin Patent
27 April
US Judge Upholds Validity Of Merck's Vytorin Patent
27 April
Orion Sues Mylan In US To Enforce Parkinson's Drug Patents
26 April
Mylan 1Q Profit Rises 24%; EpiPen Settlement Reached With Teva
26 April
TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks
25 April
TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks
24 April
Watson, Actavis To Unveil EUR4.5 Billion Merger Deal Wednesday
23 March
Mylan Introduces Educational Website About Generic Drugs, www.ChoosingGenerics.com
22 March
Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
15 February
Mylan Launches First Generic Version of Vfend® Tablets
11 February
Mylan Schedules Fourth Quarter 2010 Financial Results Conference Call and Live Webcast
28 January
Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
27 January
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
25 January
Mylan Announces Lipitor® Settlement Agreement
25 January
Mylan Announces Caduet® Settlement Agreement
24 January
Mylan's Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
20 January
Dey Pharma Launches MyEpiPen Apps for iPhone and iPad
No news for this instrument
More news
Company profile
No description
Version: LiveBranchBuild_20120516.1 - EUROWEB1 - 2012-05-22 02:20:14 - 2012-05-22 01:20:14 - 1000 - Website: OKAY